These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38889232)

  • 1. Testosterone: A Review for Orthopaedic Surgeons.
    Arcand MA; Poulin D; Testa EJ; Lemme NJ
    JBJS Rev; 2024 Jun; 12(6):. PubMed ID: 38889232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use.
    McBride JA; Coward RM
    Asian J Androl; 2016; 18(3):373-80. PubMed ID: 26908067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new testosterone gel (fortesta) for hypogonadism.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risks, contraindications, abuse and monitoring risks of testosterone replacement therapy (TRT)].
    Glina S; Wroclawski ER; Chaves OH
    Int Braz J Urol; 2006; 32 Suppl 1():31-4. PubMed ID: 23631039
    [No Abstract]   [Full Text] [Related]  

  • 6. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FPIN's clinical inquiries. Testosterone therapy and risk recurrence after treatment of prostate cancer.
    Meza J; Weaver K; Martin S
    Am Fam Physician; 2013 Oct; 88(8):Online. PubMed ID: 24364582
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
    Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
    Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and management of male androgen disorders: an update.
    Chan I; Fui MN; Zajac JD; Grossmann M
    Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study.
    Wheeler KM; Smith RP; Kumar RA; Setia S; Costabile RA; Kavoussi PK
    J Urol; 2017 Apr; 197(4):1127-1131. PubMed ID: 27984109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen replacement therapy in aging men.
    Katz A
    Nurse Pract; 2004 Oct; 29(10):58-64. PubMed ID: 15489672
    [No Abstract]   [Full Text] [Related]  

  • 13. [Testosterone replacement therapy for hypogonadism in men with prostate cancer].
    Jensen CF; Fode M; Østergren P; Sønksen J
    Ugeskr Laeger; 2017 Feb; 179(9):. PubMed ID: 28263152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternatives to Testosterone Therapy: A Review.
    Lo EM; Rodriguez KM; Pastuszak AW; Khera M
    Sex Med Rev; 2018 Jan; 6(1):106-113. PubMed ID: 29174957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone Replacement Therapy in Orthopaedic Surgery.
    Cohn RM; Ganz MP; Scuderi GR
    J Am Acad Orthop Surg; 2024 Apr; 32(8):331-338. PubMed ID: 38412226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone replacement therapy and the risk of prostate cancer.
    Warburton D; Hobaugh C; Wang G; Lin H; Wang R
    Asian J Androl; 2015; 17(6):878-81; discussion 880. PubMed ID: 25865848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).
    Maggi M; Wu FC; Jones TH; Jackson G; Behre HM; Hackett G; Martin-Morales A; Balercia G; Dobs AS; Arver ST; Maggio M; Cunningham GR; Isidori AM; Quinton R; Wheaton OA; Siami FS; Rosen RC;
    Int J Clin Pract; 2016 Oct; 70(10):843-852. PubMed ID: 27774779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of androgen therapy in men with prostate cancer.
    Rajan P; Tharakan T; Chen R
    Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101628. PubMed ID: 35248487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone replacement therapy for late-onset hypogonadism.
    Cunningham GR
    Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.